ConductScience.org, home

Trial · NCT00428792

Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD)

NCT00428792, Phase 3, Completed, Novartis; results first posted 2011-05-06

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD). Trials, record NCT00428792. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00428792

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD)
NCT number
NCT00428792
Status
Completed
Phases
Phase 3
Enrollment
150 participants, actual
Lead sponsor
Novartis
Conditions
Attention Deficit Hyperactivity Disorder
Interventions
Methylphenidate 20 mg long-acting capsules
First posted
2007-01-30
Last updated
2011-05-06
Results first posted
2011-05-06

Source ClinicalTrials.gov

Registered outcomes10

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryFremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Teacher Rating in the Intent-to-Treat (ITT) PopulationFriday of each of the 2 treatment weeks
The FBB-ADHS is a 20-item rating scale. Each item describes a typical ADHD symptom. The 20 items are divided into 3 subscales: Attention deficits (9 items), hyperactivity (7 items), and impulsiveness (4 items). Each item is rated on a scale of 0 = not at all up to 3 = very much. The FBB-ADHS was completed by teachers on Friday afternoon of each week of the study. A total score (sum of all items divided by 20) was calculated. The total score can range from 0 to 3. A lower score indicates more ADHD.
PrimaryFremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Teacher Rating in the Per Protocol (PP) PopulationFriday of each of the 2 treatment weeks
The FBB-ADHS is a 20-item rating scale. Each item describes a typical ADHD symptom. The 20 items are divided into 3 subscales: Attention deficits (9 items), hyperactivity (7 items), and impulsiveness (4 items). Each item is rated on a scale of 0 = not at all up to 3 = very much. The FBB-ADHS was completed by teachers on Friday afternoon of each week of the study. A total score (sum of all items divided by 20) was calculated. The total score can range from 0 to 3. A lower score indicates more ADHD.
SecondaryFremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Attention Deficit Subscale Teacher RatingFriday of each of the 2 treatment weeks
Teacher rating of the attention deficit subscale (9 items), one of 3 subscales in the FBB-ADHS. Each item is rated on a scale of 0 = not at all up to 3 = very much. The rating was completed by teachers on Friday afternoon of each week of the study. A total score (sum of all items divided by 9) was calculated. The total score can range from 0 to 3. A lower score indicates more ADHD.
SecondaryFremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Hyperactivity Subscale Teacher RatingFriday of each of the 2 treatment weeks
Teacher rating of the hyperactivity subscale (7 items), one of 3 subscales in the FBB-ADHS. Each item is rated on a scale of 0 = not at all up to 3 = very much. The rating was completed by teachers on Friday afternoon of each week of the study. A total score (sum of all items divided by 7) was calculated. The total score can range from 0 to 3. A lower score indicates more ADHD.
SecondaryFremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Impulsiveness Subscale Teacher RatingFriday of each of the 2 treatment weeks
Teacher rating of the hyperactivity subscale (4 items), one of 3 subscales in the FBB-ADHS. Each item is rated on a scale of 0 = not at all up to 3 = very much. The rating was completed by teachers on Friday afternoon of each week of the study. A total score (sum of all items divided by 4) was calculated. The total score can range from 0 to 3. A lower score indicates more ADHD.
SecondaryFremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Parent RatingSaturday of each of the 2 treatment weeks
The FBB-ADHS is a 20-item rating scale. Each item describes a typical ADHD symptom. The 20 items are divided into 3 subscales: Attention deficits (9 items), hyperactivity (7 items), and impulsiveness (4 items). Each item is rated on a scale of 0 = not at all up to 3 = very much. The FBB-ADHS was completed by teachers on Friday afternoon of each week of the study. A total score (sum of all items divided by 20) was calculated. The total score can range from 0 to 3. A lower score indicates more ADHD.
Secondary10-Minute Math Test - Problems AttemptedSaturday of each of the 2 treatment weeks
The 10-Minute Math Test is a paper and pencil test consisting of several pages of math problems requiring addition, subtraction, multiplication and division calculations presented in ascending order of difficulty during a 10-minute period. Test difficulty was altered for subjects at different skill levels and ages. The number of problems attempted is an objective measure related to "academic productivity". The math test was carried out on the Saturday visit at the end of each of the 2 treatment weeks under supervision of a teacher who had been trained on this test.
Secondary10-Minute Math Test - Problems SolvedSaturday of each of the 2 treatment weeks
The 10-Minute Math Test is a paper and pencil test consisting of several pages of math problems requiring addition, subtraction, multiplication and division calculations presented in ascending order of difficulty during a 10-minute period. Test difficulty was altered for subjects at different skill levels and ages. The number of problems attempted is an objective measure related to "academic productivity". The math test was carried out on the Saturday visit at the end of each of the 2 treatment weeks under supervision of a teacher who had been trained on this test.
SecondaryClinical Global Impression Severity (CGI-S) Scale Score - Physician Rating of SeveritySaturday of each of the 2 treatment weeks
The CGI-S is a scale to assess the global severity of illness. The rating is determined by the investigator answering one question: "Considering your total clinical experience with this particular population, how mentally ill is the patient at this time?" Ratings are on a 7-point scale: 1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; 7=among the most extremely ill patients. The rating is based upon the average observed and reported symptoms, behavior, and function in the past 7 days.
SecondaryClinical Global Impression (CGI-I) Scale Score - Physician Rating of Improvement (Change in State)Saturday of each of the 2 treatment weeks
The CGI-I is a scale to assess improvement (change in state) of illness. The rating is based on the investigator answering one question: "Compared to the patient's condition prior to medication, this patient's condition is: 1=very much improved since the initiation of treatment; 2=much improved; 3=minimally improved; 4=no change from baseline (the initiation of treatment); 5=minimally worse; 6= much worse; 7=very much worse since the initiation of treatment." The investigator compares the patient's overall clinical condition to the 1 week period just prior to the initiation of medication.

Outcomes10

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYFremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Teacher Rating in the Intent-to-Treat (ITT) PopulationFriday of each of the 2 treatment weeksIntent to treat (ITT) population: All randomized patients with at least one post-baseline measurement of the primary endpoint in both study periods.Units on a scaleMEAN
SECONDARYFremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Attention Deficit Subscale Teacher RatingFriday of each of the 2 treatment weeksIntent to treat (ITT) population: All randomized patients with at least one post-baseline measurement of the primary endpoint in both study periods.Units on a scaleMEAN
SECONDARYFremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Hyperactivity Subscale Teacher RatingFriday of each of the 2 treatment weeksIntent to treat (ITT) population: All randomized patients with at least one post-baseline measurement of the primary endpoint in both study periods.Units on a scaleMEAN
SECONDARYFremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Impulsiveness Subscale Teacher RatingFriday of each of the 2 treatment weeksIntent to treat (ITT) population: All randomized patients with at least one post-baseline measurement of the primary endpoint in both study periods.Units on a scaleMEAN
SECONDARYFremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Parent RatingSaturday of each of the 2 treatment weeksIntent to treat (ITT) population: All randomized patients with at least one post-baseline measurement of the primary endpoint in both study periods.Units on a scaleMEAN
PRIMARYFremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Teacher Rating in the Per Protocol (PP) PopulationFriday of each of the 2 treatment weeks
Per protocol (PP) population: All patients in the ITT population who (a) met the inclusion/exclusion criteria liable to affect the efficacy assessment and (b) did not violate the protocol in a manner liable to affect the efficacy assessment.
Units on a scaleMEAN
SECONDARY10-Minute Math Test - Problems AttemptedSaturday of each of the 2 treatment weeks
Intent to treat (ITT) population includes all randomized patients with at least one post-baseline measurement of the primary endpoint in both study periods. Following the intent-to-treat principle, patients were analyzed according to the treatment they were assigned to at randomization.
Problems attemptedMEAN
SECONDARY10-Minute Math Test - Problems SolvedSaturday of each of the 2 treatment weeksIntent to treat (ITT) population: All randomized patients with at least one post-baseline measurement of the primary endpoint in both study periods.Problems solvedMEAN
SECONDARYClinical Global Impression Severity (CGI-S) Scale Score - Physician Rating of SeveritySaturday of each of the 2 treatment weeksIntent to treat (ITT) population: All randomized patients with at least one post-baseline measurement of the primary endpoint in both study periods.Units on a scaleMEAN
SECONDARYClinical Global Impression (CGI-I) Scale Score - Physician Rating of Improvement (Change in State)Saturday of each of the 2 treatment weeks
Intent to treat (ITT) population includes all randomized patients with at least one post-baseline measurement of the primary endpoint in both study periods. Following the intent-to-treat principle, patients were analyzed according to the treatment they were assigned to at randomization.
Units on a scaleMEAN

Results by group20

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Fremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Teacher Rating in the Intent-to-Treat (ITT) PopulationVery Light Breakfast (VLB) Treatment Group0.97Standard Deviation 0.63Units on a scale
Fremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Teacher Rating in the Intent-to-Treat (ITT) PopulationStandard Breakfast (SB) Treatment Group1.01Standard Deviation 0.63Units on a scale
Fremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Attention Deficit Subscale Teacher RatingVery Light Breakfast (VLB) Treatment Group1.19Standard Deviation 0.68Units on a scale
Fremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Attention Deficit Subscale Teacher RatingStandard Breakfast (SB) Treatment Group1.23Standard Deviation 0.69Units on a scale
Fremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Hyperactivity Subscale Teacher RatingVery Light Breakfast (VLB) Treatment Group0.72Standard Deviation 0.70Units on a scale
Fremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Hyperactivity Subscale Teacher RatingStandard Breakfast (SB) Treatment Group0.75Standard Deviation 0.69Units on a scale
Fremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Impulsiveness Subscale Teacher RatingVery Light Breakfast (VLB) Treatment Group0.93Standard Deviation 0.92Units on a scale
Fremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Impulsiveness Subscale Teacher RatingStandard Breakfast (SB) Treatment Group0.99Standard Deviation 0.90Units on a scale
Fremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Parent RatingVery Light Breakfast (VLB) Treatment Group1.15Standard Deviation 0.60Units on a scale
Fremdbeurteilungsbogen für Aufmerksamkeitsdefizit-Hyperaktivitätsstörungen (FBB-AHDS) Parent RatingStandard Breakfast (SB) Treatment Group1.11Standard Deviation 0.55Units on a scale

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDVery Light Breakfast (VLB) Then Standard Breakfast (SB)80
Overall StudySTARTEDStandard Breakfast (SB) Then Very Light Breakfast (VLB)70
Overall StudyCOMPLETEDVery Light Breakfast (VLB) Then Standard Breakfast (SB)79
Overall StudyCOMPLETEDStandard Breakfast (SB) Then Very Light Breakfast (VLB)66
Overall StudyNOT COMPLETEDVery Light Breakfast (VLB) Then Standard Breakfast (SB)1
Overall StudyNOT COMPLETEDStandard Breakfast (SB) Then Very Light Breakfast (VLB)4

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityVery Light Breakfast (VLB) Then Standard Breakfast (SB)
Total, all-cause mortalityStandard Breakfast (SB) Then Very Light Breakfast (VLB)
Total, other adverse eventsVery Light Breakfast (VLB) Then Standard Breakfast (SB)0148
Total, other adverse eventsStandard Breakfast (SB) Then Very Light Breakfast (VLB)0149
Total, serious adverse eventsVery Light Breakfast (VLB) Then Standard Breakfast (SB)0148
Total, serious adverse eventsStandard Breakfast (SB) Then Very Light Breakfast (VLB)0149

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons1

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

Comparison
Very Light Breakfast (VLB) Then Standard Breakfast (SB) vs Standard Breakfast (SB) Then Very Light Breakfast (VLB): serious adverse events

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00428792

GET https://conductscience.org/api/trials/v1/NCT00428792/registered